在头癌症中使用他类药物的影响:一个嵌套的病例控制研究
Haewon Rhi1, Hyo Geun Choi2, Jeong Wook Kang3
1Department of Otorhinolaryngology-Head & Neck Surgery, Hallym University Sacred Heart Hospital, Anyang, 14068, Republic of Korea.
脱脂症可能会降低头癌 (HNC) 的风险. 然而,短期使用他类药物会增加HNC的几率,而长期使用没有增加风险.
科学领域:
- 在瘤学瘤学.
- 心血管医学 心血管医学
- 流行病学 流行病学
背景情况:
- 脱脂症和他类药物的使用与各种癌症有关.
- 与头癌 (HNC) 的特定关联尚未得到充分证实.
研究的目的:
- 为了研究失脂症和他类药物的使用对HNC发育的影响.
- 分析失脂症,他类药物治疗持续时间和HNC风险之间的关系.
主要方法:
- 利用了韩国国家医疗保险服务-国家样本队列数据 (2002-2019).
- 1006名HNC患者与4024名使用倾向性得分重叠加权衡平衡的匹配对照进行了比较.
- 通过基于失脂症和他类药物使用时间的加权多变量逻辑回归评估HNC发展的概率比率.
主要成果:
- 未经治疗的脂质失调与明显较低的HNC几率 (OR0.70) 有关.
- 在失脂症患者中,短期使用他类药物 (<60天) 几乎使HNC的几率翻了一番 (OR 1.94).
- 长期使用他类药物 (≥60天) 将HNC的几率正常化 (OR 0.89).
结论:
- 短期使用他类药物可能会对HNC的发展产生不利影响,需要进一步调查.
- 治疗失脂症的长期他类药物治疗似乎不会增加头癌的风险.
更多相关视频
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
06:08Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
Published on: June 2, 2023
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Drugs that Stabilize Microtubules
Atherosclerosis III: Management
Cancer Prevention
Some...
